Weighted and combined multi-gene pharmacogenomic testing significantly increased clinical response and remission rates for patients with major depressive disorder.
All articles by Kwamesha Joseph
Safety, symptoms, and illness trajectory of outpatients with schizophrenia who received ongoing aripiprazole lauroxil were followed for 2 years.
Latest News Your top articles for SaturdayFor More Personalized News
Haymarket Medical NetworkTop Picks
Continuing Medical Education (CME/CE) Courses